Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat.
A plasma flow rate-limited pharmacokinetic model was developed to describe the distribution of digoxin to the heart, liver, kidneys, skeletal muscle, and GI tract in the rat. The model also provides for renal, hepatic (metabolic and biliary), and GI clearance as well as for biliary and GI secretion and GI reabsorption of digoxin. Predicted concentrations of digoxin in the heart, liver, skeletal muscle, and plasma were consistent with experimental observations in conscious rats after an intravenous dose. The model was extended to describe digoxin concentrations in the plasma of bile duct-ligated rats and ureter-ligated rats, simply by modifying appropriate clearance parameters. Excellent agreement was obtained between predicted and observed urinary excretion rates of digoxin for 12 hr after in intravenous dose to normal and bile duct-ligated rats.
D000818:Animals; D003135:Common Bile Duct / Q000502:physiology; D004077:Digoxin / Q000008:administration & dosage / Q000378:metabolism*; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D051381:Rats; D013997:Time Factors; D014513:Ureter / Q000502:physiology
D004077:Digoxin